Treace Medical Concepts, Inc. (TMCI) Operating income 2019–2025
Treace Medical Concepts, Inc. (TMCI) annual operating income history from SEC filings — each fiscal year as reported.
-$54.2MFY2025 · since FY2019: -$3.5M → -$54.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$54.2M | +2.8% |
| FY2024 | -$55.7M | -8.3% |
| FY2023 | -$51.4M | -47.6% |
| FY2022 | -$34.8M | -111.0% |
| FY2021 | -$16.5M | -2031.0% |
| FY2020 | $855,000 | +124.2% |
| FY2019 | -$3.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TMCI financial trends
TMCI RevenueTMCI Net incomeTMCI Net marginTMCI Gross profitTMCI Gross marginTMCI Operating marginTMCI Operating cash flowTMCI Free cash flowTMCI Capital expendituresTMCI Return on equityTMCI Stock buybacksTMCI Dividends paidTMCI Total assetsTMCI Total liabilitiesTMCI Shareholders’ equityTMCI overview →